International Stem Cell ISCO
OTC ISCO
$0.21 -0.05 (-19.23%)
As of: Oct 21, 2026 · 10:19 AM EDT

International Stem Cell (ISCO) Ending Cash Balance (2017 - 2026)

Updated

Analysis

International Stem Cell (ISCO) Ending Cash Balance (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.42 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.57 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.03 Bn
10 International Stem Cell 1.36 Mn -2.61 Mn 1.46 Mn 1.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.09 Mn
Dec 31, 2025 993,000.00
Sep 30, 2025 966,000.00
Jun 30, 2025 920,000.00
Mar 31, 2025 1.45 Mn
Dec 31, 2024 1.23 Mn
Sep 30, 2024 1.31 Mn
Jun 30, 2024 1.29 Mn
Mar 31, 2024 1.39 Mn
Dec 31, 2023 1.59 Mn
Sep 30, 2023 1.43 Mn
Jun 30, 2023 1.38 Mn
Mar 31, 2023 943,000.00
Dec 31, 2022 742,000.00
Sep 30, 2022 666,000.00
Jun 30, 2022 586,000.00
Mar 31, 2022 398,000.00
Dec 31, 2021 171,000.00
Sep 30, 2021 505,000.00
Jun 30, 2021 750,000.00
API Access

International Stem Cell Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ISCO&period=max&api_key=YOUR_API_KEY